DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+8.43%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$34.3B
AUM Growth
+$4.15B
(+14%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
5.59%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54
Top Buys
| 1 |
Stellantis
STLA
|
$207M |
| 2 |
Amazon
AMZN
|
$131M |
| 3 |
Deutsche Bank
DB
|
$104M |
| 4 |
Intuitive Surgical
ISRG
|
$100M |
| 5 |
Tesla
TSLA
|
$86.5M |
Top Sells
| 1 |
Broadcom
AVGO
|
$129M |
| 2 |
XPeng
XPEV
|
$101M |
| 3 |
Abbott
ABT
|
$79.1M |
| 4 |
BioNTech
BNTX
|
$56.2M |
| 5 |
VF Corp
VFC
|
$47.9M |
Sector Composition
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.46% |
| 3 | Financials | 11.88% |
| 4 | Communication Services | 9.65% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
1126
DELISTED
Endo International plc
ENDP
| $352K | ﹤0.01% |
76,600
| – | – |
|
1127
Nurix Therapeutics
NRIX
$706M
| $344K | ﹤0.01% |
12,400
| – | – |
|
1128
Melco Resorts & Entertainment
MLCO
$3.89B
| $341K | ﹤0.01% |
21,140
+761
| +4% | +$12.3K |
|
1129
DoorDash
DASH
$106B
| $336K | ﹤0.01% |
+1,825
| New | +$336K |
|
1130
Globant
GLOB
$2.78B
| $334K | ﹤0.01% |
1,500
-510
| -25% | -$114K |
|
1131
Pliant Therapeutics
PLRX
$100M
| $333K | ﹤0.01% |
12,000
| – | – |
|
|
ZGNX
1132
DELISTED
Zogenix, Inc.
ZGNX
| $329K | ﹤0.01% |
18,600
| – | – |
|
1133
Imperial Oil
IMO
$44.6B
| $324K | ﹤0.01% |
10,844
+777
| +8% | +$23.2K |
|
1134
Schneider National
SNDR
$4.34B
| $322K | ﹤0.01% |
14,909
| – | – |
|
1135
Arcutis Biotherapeutics
ARQT
$1.96B
| $320K | ﹤0.01% |
12,400
| – | – |
|
1136
Avidity Biosciences
RNA
$6.34B
| $320K | ﹤0.01% |
14,000
| – | – |
|
1137
Nkarta
NKTX
$154M
| $312K | ﹤0.01% |
10,500
| – | – |
|
1138
Ocular Therapeutix
OCUL
$2.23B
| $312K | ﹤0.01% |
22,900
| – | – |
|
1139
Bausch Health
BHC
$2.67B
| $309K | ﹤0.01% |
10,716
+513
| +5% | +$14.8K |
|
1140
Immunovant
IMVT
$2.85B
| $309K | ﹤0.01% |
28,600
| – | – |
|
1141
Akero Therapeutics
AKRO
$3.56B
| $305K | ﹤0.01% |
12,000
| – | – |
|
1142
CAE Inc
CAE
$8.49B
| $304K | ﹤0.01% |
10,024
+860
| +9% | +$26.1K |
|
1143
Amphastar Pharmaceuticals
AMPH
$1.37B
| $299K | ﹤0.01% |
14,900
| – | – |
|
1144
Axon Enterprise
AXON
$56.1B
| $297K | ﹤0.01% |
1,654
+670
| +68% | +$120K |
|
1145
Service Corp International
SCI
$11B
| $295K | ﹤0.01% |
5,526
+4,684
| +556% | +$250K |
|
1146
Teva Pharmaceuticals
TEVA
$21.4B
| $295K | ﹤0.01% |
29,365
+4,665
| +19% | +$46.9K |
|
1147
Precigen
PGEN
$1.34B
| $294K | ﹤0.01% |
46,500
| – | – |
|
1148
Corsair Gaming
CRSR
$948M
| $293K | ﹤0.01% |
9,000
+1,000
| +13% | +$32.6K |
|
1149
Dolby
DLB
$6.97B
| $293K | ﹤0.01% |
2,956
+468
| +19% | +$46.4K |
|
1150
Icon
ICLR
$13.8B
| $291K | ﹤0.01% |
1,357
-22,000
| -94% | -$4.72M |
|